0000912282-23-000579.txt : 20231220
0000912282-23-000579.hdr.sgml : 20231220
20231220175810
ACCESSION NUMBER: 0000912282-23-000579
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231212
FILED AS OF DATE: 20231220
DATE AS OF CHANGE: 20231220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VITA NICHOLAS
CENTRAL INDEX KEY: 0001907623
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-56294
FILM NUMBER: 231502379
MAIL ADDRESS:
STREET 1: C/O COLUMBIA CARE INC.
STREET 2: 680 FIFTH AVENUE, 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cannabist Co Holdings Inc.
CENTRAL INDEX KEY: 0001776738
STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 981488978
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 680 FIFTH AVENUE, 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 2125543424
MAIL ADDRESS:
STREET 1: 680 FIFTH AVENUE, 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: Columbia Care Inc.
DATE OF NAME CHANGE: 20190514
4
1
form4.xml
X0508
4
2023-12-12
0001776738
Cannabist Co Holdings Inc.
CBSTF
0001907623
VITA NICHOLAS
C/O THE CANNABIST COMPANY HOLDINGS INC.
680 FIFTH AVENUE, 24TH FLOOR
NEW YORK
NY
10019
true
true
Chief Executive Officer
false
Common Shares
2023-12-12
4
S
0
200000
0.375
D
19827075
I
Held by Vita Holdings LLC
Common Shares
2023-12-18
4
S
0
100000
0.396
D
19727075
I
Held by Vita Holdings LLC
Common Shares
618950
D
The sales price reported above was converted from the Canadian sales price of $0.51 using an exchange rate of C$1.3599 = US$1.00.
The sale price reported above was converted from the Canadian sale price of C$0.53 using an exchange rate of C$1.3387 = US$1.00.
Shares sold by third-party financial institution in partial satisfaction of debt obligation. Funding was primarily used for pediatric medical research for orphan and ultra rare illnesses, tax payments, education and philanthropic purposes.
/s/ Nicholas Vita
2023-12-20